Versant Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$86	Sell	17 -1,218	-99%	-$6.16K	﹤0.01%	2619
2025 Q1	$6.53K	Buy	1,235 +54	+5%	+$286	﹤0.01%	1920
2024 Q4	$7.98K	Buy	1,181 +1,034	+703%	+$6.99K	﹤0.01%	1526
2024 Q3	$969	Buy	+147	New	+$969	﹤0.01%	1749